Federated Hermes Inc. Has $3.49 Million Position in Aveanna Healthcare Holdings Inc. $AVAH

Federated Hermes Inc. boosted its position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 226.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 393,155 shares of the company’s stock after purchasing an additional 272,561 shares during the quarter. Federated Hermes Inc.’s holdings in Aveanna Healthcare were worth $3,487,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. Quantbot Technologies LP acquired a new stake in shares of Aveanna Healthcare during the second quarter worth $43,000. MQS Management LLC bought a new position in Aveanna Healthcare during the second quarter worth about $59,000. Belvedere Trading LLC acquired a new stake in Aveanna Healthcare in the 2nd quarter worth about $62,000. Oxford Asset Management LLP bought a new stake in Aveanna Healthcare in the 2nd quarter valued at about $64,000. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Aveanna Healthcare in the 2nd quarter valued at about $68,000. Institutional investors own 87.96% of the company’s stock.

Aveanna Healthcare Trading Up 1.6%

Shares of AVAH opened at $8.46 on Wednesday. The company has a debt-to-equity ratio of 140.39, a quick ratio of 1.23 and a current ratio of 1.23. Aveanna Healthcare Holdings Inc. has a 52-week low of $3.67 and a 52-week high of $10.32. The firm has a market cap of $1.77 billion, a price-to-earnings ratio of 23.50 and a beta of 2.06. The business’s fifty day moving average is $8.82 and its 200-day moving average is $8.18.

Aveanna Healthcare (NASDAQ:AVAH) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.15 earnings per share for the quarter, topping the consensus estimate of $0.07 by $0.08. Aveanna Healthcare had a negative return on equity of 143.55% and a net margin of 3.29%.The business had revenue of $621.94 million during the quarter, compared to the consensus estimate of $578.57 million. Equities analysts anticipate that Aveanna Healthcare Holdings Inc. will post -0.06 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on the stock. Truist Financial raised their target price on shares of Aveanna Healthcare from $9.50 to $10.00 and gave the stock a “hold” rating in a report on Friday, November 7th. BMO Capital Markets began coverage on Aveanna Healthcare in a research note on Thursday, November 13th. They set an “outperform” rating and a $11.00 price objective on the stock. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Aveanna Healthcare in a report on Monday, December 29th. Royal Bank Of Canada upped their target price on Aveanna Healthcare from $10.00 to $11.00 and gave the company a “sector perform” rating in a research report on Thursday, January 15th. Finally, Jefferies Financial Group raised their price target on Aveanna Healthcare from $11.00 to $12.50 and gave the stock a “buy” rating in a research report on Tuesday, October 28th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Aveanna Healthcare currently has an average rating of “Moderate Buy” and a consensus target price of $11.06.

Insider Buying and Selling

In other Aveanna Healthcare news, CEO Jeff Shaner sold 29,357 shares of the firm’s stock in a transaction that occurred on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $230,452.45. Following the sale, the chief executive officer owned 2,394,179 shares in the company, valued at $18,794,305.15. This trade represents a 1.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Patrick A. Cunningham sold 12,445 shares of the firm’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $7.85, for a total value of $97,693.25. Following the sale, the insider directly owned 293,354 shares in the company, valued at approximately $2,302,828.90. This trade represents a 4.07% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 259,638 shares of company stock worth $2,109,595 in the last quarter. Corporate insiders own 7.00% of the company’s stock.

Aveanna Healthcare Profile

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.